NO20006320L - Cykliske somatostatin-analoger - Google Patents
Cykliske somatostatin-analogerInfo
- Publication number
- NO20006320L NO20006320L NO20006320A NO20006320A NO20006320L NO 20006320 L NO20006320 L NO 20006320L NO 20006320 A NO20006320 A NO 20006320A NO 20006320 A NO20006320 A NO 20006320A NO 20006320 L NO20006320 L NO 20006320L
- Authority
- NO
- Norway
- Prior art keywords
- present
- somatostatin analogues
- relates
- cyclic somatostatin
- somatostatin
- Prior art date
Links
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 102000005157 Somatostatin Human genes 0.000 abstract 1
- 108010056088 Somatostatin Proteins 0.000 abstract 1
- 108050001286 Somatostatin Receptor Proteins 0.000 abstract 1
- 102000011096 Somatostatin receptor Human genes 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003278 mimic effect Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 229960000553 somatostatin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8950398P | 1998-06-16 | 1998-06-16 | |
| US9818198A | 1998-06-16 | 1998-06-16 | |
| PCT/US1999/013304 WO1999065942A1 (en) | 1998-06-16 | 1999-06-11 | Cyclic somatostatin analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006320D0 NO20006320D0 (no) | 2000-12-12 |
| NO20006320L true NO20006320L (no) | 2001-02-12 |
Family
ID=26780645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006320A NO20006320L (no) | 1998-06-16 | 2000-12-12 | Cykliske somatostatin-analoger |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1086131A1 (es) |
| JP (1) | JP2002518409A (es) |
| CN (1) | CN1200000C (es) |
| AR (1) | AR021161A1 (es) |
| AU (1) | AU745493B2 (es) |
| CA (1) | CA2335184A1 (es) |
| HU (1) | HUP0102902A3 (es) |
| NO (1) | NO20006320L (es) |
| PL (1) | PL345037A1 (es) |
| RU (1) | RU2242481C2 (es) |
| TW (3) | TWI242441B (es) |
| WO (1) | WO1999065942A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1086086E (pt) | 1998-06-12 | 2005-02-28 | Sod Conseils Rech Applic | Derivados imidazolilo e sua utilizacao como ligandos de receptores da somatostatina |
| FR2796945B1 (fr) * | 1999-07-30 | 2002-06-28 | Sod Conseils Rech Applic | Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments |
| ES2282275T3 (es) * | 2000-08-01 | 2007-10-16 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derivados de imidazolilo. |
| US20040186151A1 (en) * | 2003-02-12 | 2004-09-23 | Mjalli Adnan M.M. | Substituted azole derivatives as therapeutic agents |
| WO2006063465A1 (en) * | 2004-12-15 | 2006-06-22 | Diamedica Inc. | Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists |
| ES2365815T3 (es) * | 2005-12-14 | 2011-10-11 | Bristol-Myers Squibb Company | Análogos de arilpropionamida, arilacrilamida, arilpropinamida o arilmetilurea como inhibidores del factor xia. |
| JP5225098B2 (ja) * | 2005-12-14 | 2013-07-03 | ブリストル−マイヤーズ スクイブ カンパニー | 第ＸＩａ因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ |
| PT2337846T (pt) | 2008-09-26 | 2018-04-05 | Ambrx Inc | Vacinas e microrganismos dependentes da replicação de aminoácidos não naturais |
| EP2168983A1 (fr) * | 2008-09-30 | 2010-03-31 | Ipsen Pharma | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
| JP5535931B2 (ja) | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | 二環性化合物 |
| RU2020143060A (ru) | 2016-02-09 | 2021-02-20 | СиДиАрДи ВЕНЧЕРЗ ИНК. | Антагонисты рецепторов соматостатина и способы их применения |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770687A (en) * | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
| GB9513224D0 (en) * | 1995-06-29 | 1995-09-06 | Sandoz Ltd | Organic compounds |
| US6673927B2 (en) * | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
-
1999
- 1999-06-11 JP JP2000554767A patent/JP2002518409A/ja active Pending
- 1999-06-11 CN CNB998075027A patent/CN1200000C/zh not_active Expired - Fee Related
- 1999-06-11 WO PCT/US1999/013304 patent/WO1999065942A1/en not_active Ceased
- 1999-06-11 CA CA002335184A patent/CA2335184A1/en not_active Abandoned
- 1999-06-11 PL PL99345037A patent/PL345037A1/xx not_active Application Discontinuation
- 1999-06-11 HU HU0102902A patent/HUP0102902A3/hu unknown
- 1999-06-11 AU AU48223/99A patent/AU745493B2/en not_active Ceased
- 1999-06-11 EP EP99931793A patent/EP1086131A1/en not_active Withdrawn
- 1999-06-11 RU RU2001101530/04A patent/RU2242481C2/ru not_active IP Right Cessation
- 1999-06-15 TW TW091115003A patent/TWI242441B/zh active
- 1999-06-15 AR ARP990102857A patent/AR021161A1/es unknown
- 1999-06-15 TW TW088110016A patent/TW527361B/zh not_active IP Right Cessation
- 1999-06-15 TW TW093100348A patent/TWI242442B/zh active
-
2000
- 2000-12-12 NO NO20006320A patent/NO20006320L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2242481C2 (ru) | 2004-12-20 |
| TWI242442B (en) | 2005-11-01 |
| AU4822399A (en) | 2000-01-05 |
| NO20006320D0 (no) | 2000-12-12 |
| JP2002518409A (ja) | 2002-06-25 |
| TWI242441B (en) | 2005-11-01 |
| WO1999065942A1 (en) | 1999-12-23 |
| EP1086131A1 (en) | 2001-03-28 |
| AU745493B2 (en) | 2002-03-21 |
| WO1999065942A8 (en) | 2000-02-17 |
| CN1305496A (zh) | 2001-07-25 |
| TW527361B (en) | 2003-04-11 |
| HUP0102902A2 (hu) | 2002-01-28 |
| PL345037A1 (en) | 2001-11-19 |
| TW200410986A (en) | 2004-07-01 |
| CA2335184A1 (en) | 1999-12-23 |
| AR021161A1 (es) | 2002-07-03 |
| HUP0102902A3 (en) | 2002-02-28 |
| CN1200000C (zh) | 2005-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005021494D1 (de) | Substituierte pyrazole, derartige verbindungen enthaltende zusammensetzungen und verfahren zu ihrer verwendung | |
| DE69835225D1 (de) | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen | |
| TW200745031A (en) | Acyl indoles, compositions containing such compounds and methods of use | |
| NO20006320L (no) | Cykliske somatostatin-analoger | |
| YU34898A (sh) | Antagonisti ccr-3 receptora | |
| WO2004069158A3 (en) | Substituted pyrazoles, compositions containing such compounds and methods of use | |
| ATE377606T1 (de) | Zyklische antagonisten der c5a rezeptoren sowie der g-protein gekoppelten rezeptoren | |
| DE602007014102D1 (de) | Verfahren zur behandlung oder vorbeugung von symptomen hormoneller veränderungen | |
| ATE393781T1 (de) | Somatostatin analoge, deren radiomarkierte derivate und deren verwendung | |
| ATE508633T1 (de) | Eprosartan-zusammensetzungen | |
| IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
| DE50114321D1 (de) | REZEPTOR DER EDb-FIBRONEKTIN-DOMÄNE (II) | |
| MX2007004661A (es) | Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3. | |
| DE60010758D1 (de) | Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten | |
| DE69803883D1 (de) | Neue verbindungen, welche antagonisten sind für p2-purinorezeptor 7-transmembran (tm) g-protein gekoppelte rezeptoren | |
| EP1248641A4 (en) | USE OF A COMPOSITION BASED ON EMAP II RECEPTOR ANTAGONISTS IN THE TREATMENT OF PULMONARY HYPERTENSION | |
| EA200300850A1 (ru) | Применение антагонистов рецептора gal3 при лечении депрессии и/или тревоги и соединения, полезные в таких способах | |
| DE60135773D1 (en) | Assays | |
| ATE380048T1 (de) | Behandlung der männlichen sexuellen dysfunktion | |
| DE602005019090D1 (de) | Pyrrolidin-2-on-Derivate zur Verwendung als DP1-Rezeptoragonisten | |
| BRPI0408979A (pt) | uso de um antagonista e receptor de tipo 1 da angiotensina ii sozinho ou em combinação com uma substáncia anti-hipertensiva metabolicamente neutra, e, método para o tratamento e/ou prevenção de sìndrome metabólica | |
| ATE320005T1 (de) | Testverfahren für agonisten oder antagonisten der bindung von dynorphin a an den mas-rezeptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |